CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CLI Liquidating Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CLI Liquidating Corp
47266 Benicia Street
Phone: (510) 354-0300p:510 354-0300 Fremont, CA  94538-7330  United States Fax: (510) 657-4476f:510 657-4476

On 1/10/2012, the Company's bankruptcy case (#10-74445) was closed in the U.S. Bankruptcy Court for the Northern District of California.
On 8/01/2013, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of CLI Liquidating Corp for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.

Business Summary
CLI Liquidating Corp, formerly Cardima, Inc., is a medical device company focused on the diagnosis and treatment of cardiac arrhythmias. Arrhythmias develop from abnormal electrical currents within the heart, and can be associated with fast, slow and/or irregular heartbeats. The arrhythmias are symptomatic, and some are associated with morbidity and even mortality. Its products have been developed for the diagnosis and treatment of the two common forms of arrhythmias, atrial fibrillation (AF) and ventricular tachycardia (VT). Its products include the PATHFINDER and REVELATION Series of diagnostic catheters, the VUEPORT and NAVIPORT Series of guiding catheters, the INTELLITEMP Energy Management Device and the Surgical Ablation System. The PATHFINDER Series of microcatheters are small, flexible wire based devices. Their design makes them the Go-To catheter for all difficult procedures when accessing and mapping in the coronary sinus.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201012/31/2009YesYesYes--

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Interim President and Chief Executive Officer, Director PhillipRadlick 72 11/30/2010 11/1/1994

General Information
Number of Employees: 78 (As of 3/15/2010)
Outstanding Shares: 14,398,472 (As of 8/10/2010)
Shareholders: 244
Stock Exchange: OTC
Federal Tax Id: 943177883
Fax Number: (510) 657-4476
Email Address: info@cardima.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023